Figure 2

(a, b) Effects of the PPARδ-agonist in 2K1C animals on plasma renin and Ang II levels; results are means±s.e., n=6/group. (a) Plasma renin; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. (b) Plasma Ang II; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. (c–e) Effects of the PPARδ-agonist in 2K1C animals on plasma cytokines and adiponectin levels; results are means±s.e., n=6/group. (c) Plasma IL-6; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. (d) Plasma MCP-1; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. (e) Plasma adiponectin levels; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW.